Lupin Limited (LUPIN) Gets FDA Tentative Nod for Apixaban Oral Suspension
Lupin Limited received tentative U.S. FDA approval for its 505(b)(2) Apixaban Oral Suspension 1.25 mg/mL. Final approval is pending; manufacturing would occur at its Somerset, New Jersey facility.Material DetailsContext by AI AnalystThis is an early regulatory milestone for a differentiated take on…